Status:
NOT_YET_RECRUITING
Anti-citrullinated SR-A Peptide (Anti-csp) Antibody as a Biomarker in Rheumatoid Arthritis (RA).
Lead Sponsor:
Walaa sharif Eid Ahmed
Conditions:
Rheumatoid Arthritis (RA)
Eligibility:
All Genders
18+ years
Brief Summary
1. To measure serum level of anticitrullinated SR-A peptide antibody (anti-CSP) in RA patients compared to healthy controls . 2. To assess the diagnostic performance of anti-CSP for RA specifically se...
Detailed Description
Rheumatoid arthritis (RA) is a common a chronic autoimmune disease that can lead to joint destruction, disability, and premature mortality .Early diagnosis is crucial for preventing long-term damage a...
Eligibility Criteria
Inclusion
- Adults (≥18 years old)
Exclusion
- Patients with other autoimmune or connective tissue diseases (e.g., SLE, SS) .
- Patients with chronic infections or malignancies .
- Patients less than18 years old .
Key Trial Info
Start Date :
January 1 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT07147127
Start Date
January 1 2026
End Date
December 1 2027
Last Update
August 28 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.